Search
for
Sort by
Research 61–90 of 1000+
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients.
- Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
- The use of phosphodiesterase inhibitors for the treatment of alopecia
- Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areata
- Epidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent?
- Aromatase inhibitor–induced hair loss in two adolescents
- A New Era of 5α-Reductase Inhibitors for Androgenetic Alopecia
- Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era
- Natural Product-InspiredBis(trifluoromethyl) PhenylHydroxycinnamate Derivatives as Promising Nonsteroidal Inhibitorsof Human Steroid 5α-Reductase Type-1: Synthesis, <i>InVitro</i>, and <i>In Silico</i> Studies
- Common Topical Medications
- MARIO LACOUTURE: How Do I Treat a Patient with Dermatologic Toxicities to EGFR Inhibitors?
- A case of aromatase inhibitor‐induced alopecia successfully treated with low‐dose oral minoxidil
- Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: A clinical and immunopathologic evaluation
- Alopecia Areata, triggered by psychological stress and successfully treated with a Janus kinase inhibitor. Case report
- Exploring the Use of Topical Tofacitinib in Pediatric Alopecia Totalis
- Topical Ruxolitinib in Combination with Oral Minoxidil Results in Hair Regrowth in a Patient with Central Centrifugal Cicatricial Alopecia and Concomitant Traction Alopecia
- Resolution of Discoid Lupus Alopecia With Systemic Hydroxychloroquine and Topical Pimecrolimus Combination Therapy
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- In Vitro and In Vivo Skin Distribution of 5α-Reductase Inhibitors Loaded Into Liquid Crystalline Nanoparticles
- Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream
- Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia
- 691 Topical curcumin promotes induction of the murine hair cycle
- Topical tofacitinib in treatment of alopecia areata
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- Tumor necrosis factor-alpha inhibitor associated psoriasiform alopecia (drug-induced psoriasiform alopecia)
- Sexual dysfunction associated with 5α-reductase inhibitors in the treatment of androgenetic alopecia: a systematic review
- 440 Topical application of anti-cancer drug Bortezomib stimulates proliferation of follicular cells and induces expression of hair keratins via GATA-3 transcription factor